退行性胸椎脊髓病定量疼痛结局的系统评价与荟萃分析。
完整摘要 · 中文译文
引言:退行性胸椎脊髓病(DTM)是指继发于退行性病理的胸段脊髓症状性压迫,包括胸椎间盘突出(TDH)、黄韧带骨化(OLF)和后纵韧带骨化(OPLL)。感觉运动障碍和括约肌功能障碍常伴随疼痛,但疼痛及疼痛相关功能障碍结局的定量特征描述仍有限。我们旨在综合DTM的定量疼痛结局。 方法:本综述在PROSPERO注册(CRD420261297878),并按照PRISMA指南实施。检索MEDLINE和Embase,自建库至2025年12月。筛选和数据提取由两人独立完成,所有偏倚风险评分均经过交叉核对。对于有足够数据估计疼痛变化标准差的队列,采用随机效应荟萃分析综合研究结果。未纳入荟萃分析的队列按照SWiM指南进行综合。 结果:28项研究、34个队列共1,225例患者符合纳入标准。每个队列在手术后均有改善(视觉模拟量表(VAS)为34/34;Oswestry功能障碍指数(ODI)为10/10)。在19个可加权的VAS队列(578例患者)中,合并减少量为3.45 cm(95% CI 2.88-4.03;I2 = 94.5%);在9个可加权的ODI队列(145例患者)中,合并减少量为29.4分(20.9-37.8;I2 = 97.3%)。合并VAS减少量在TDH中为4.06 cm,在O中为3.34 cm 低频队列。无法加权的10个VAS队列(436例患者)采用描述性方法进行综合,所报告平均下降幅度的中位数为4.28 cm(IQR 3.85-4.63)。椎间盘切除术联合或不联合融合术均报告了相似的下降幅度。仅六项研究将轴向疼痛与非轴向疼痛分别报告;需要对疼痛亚型进行一致的区分并对疼痛测量指标进行标准化报告,以强化证据基础。 结论:针对退变性椎间盘源性疼痛(DTM)的手术似乎与疼痛及疼痛相关功能障碍的减轻相关,尽管存在显著异质性且研究为无对照设计,意味着目前证据的确定性非常低。 系统评价注册:PROSPERO,CRD420261297878。
完整摘要 · 英文原文
INTRODUCTION: Degenerative thoracic myelopathy (DTM) refers to symptomatic compression of the thoracic spinal cord secondary to degenerative pathology, including thoracic disc herniation (TDH), ossification of the ligamentum flavum (OLF) and ossification of the posterior longitudinal ligament (OPLL). Sensorimotor impairments and sphincter dysfunction often accompany pain, yet quantitative characterisation of pain and pain-related functional disability outcomes remains limited. We aimed to synthesise quantitative pain outcomes in DTM. METHODS: The review was registered with PROSPERO (CRD420261297878) and conducted following PRISMA guidelines. MEDLINE and Embase were searched from inception until December 2025. Screening and data extraction were performed in duplicate and all risk-of-bias scoring was cross-checked. Findings were synthesised by random-effects meta-analyses for cohorts with sufficient data to estimate the standard deviation of change in pain. Cohorts not included in the meta-analysis were synthesised following the SWiM guidelines. RESULTS: Twenty-eight studies comprising 1,225 patients within 34 cohorts met inclusion criteria. Every cohort improved after surgery (34/34 for the visual analogue scale (VAS); 10/10 for the Oswestry Disability Index (ODI)). In the 19 VAS cohorts that could be weighted (578 patients), the pooled reduction was 3.45 cm (95% CI 2.88-4.03; I2 = 94.5%), and in the nine ODI cohorts that could be weighted (145 patients) the pooled reduction was 29.4 points (20.9-37.8; I2 = 97.3%). The pooled VAS reduction was 4.06 cm in TDH and 3.34 cm in OLF cohorts. The 10 VAS cohorts that could not be weighted (436 patients) were synthesised descriptively, with a median of the reported mean reductions of 4.28 cm (IQR 3.85-4.63). Similar reductions were reported for discectomy with and without fusion. Only six studies reported axial pain separately from non-axial pain; consistent differentiation of pain subtypes and standardised reporting of pain measures are needed to strengthen the evidence base. CONCLUSION: Surgery for DTM appears to be associated with reductions in pain and pain-related functional disability, although substantial heterogeneity and the uncontrolled design of studies mean that certainty of the evidence is currently very low. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD420261297878.